newsfilter
← Latest News
GlobeNewswire·

Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025

BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans